Mylan provides lifesaving therapies for both emergency and on-going humanitarian programs
Mylan, one of the world’s largest generics and specialty pharmaceutical companies, is a longtime partner of Direct Relief. In addition to regular support of healthcare providers across the US and around the world, Mylan has been an integral partner in Direct Relief’s emergency response efforts, including but not limited to: the earthquakes in Haiti, Hurricane Sandy, the Ebola outbreaks, the Nepal earthquake, the on-going Syrian refugee crisis, Hurricanes Irma and Maria in Puerto Rico, and COVID-19 response.
Importantly, Mylan provides regular donations of essential, chronic disease, and specialty medicines that allow for healthcare strengthening in many of the poorest countries of the world, which often lack access to required therapies for their underserved populations. In addition, Mylan has played an integral role in Direct Relief’s global COVID-19 response, by providing large quantities of required antibiotics that are being used to treat ICU patients suffering from respiratory infections, pneumonia, and septic shock.
“Mylan has a long-standing history of partnering with Direct Relief that is driven by our shared passion to provide access to medicines, especially in moments of crisis. Direct Relief’s urgent and comprehensive response to fighting COVID-19 is inspiring, and we are proud to contribute to their efforts,” said Mylan Chief Commercial Officer Tony Mauro.
